Synthesis of N-alkylated chitosan and its interactions with blood

Artificial Cells, Nanomedicine, and Biotechnology
Yuchen HuangWei Xue

Abstract

When hydrophobically modified chitosan (HM-CHI) comes into contact with red blood cells (RBCs), it can cause agglomeration. This property leads HM-CHI to be a potential agent to form a rapid haemostatic plug to stop bleeding at wound sites. In this study, we investigated the properties of the HM-CHI biopolymer to act as an agent that rapidly clots blood. We have examined the synthesis and structural characteristics of HM-CHI - blood substances using X-ray diffraction, infrared spectroscopy and elemental analysis. To understand the rheological behaviour of RBCs within HM-CHI, we have studied the effects of HM-CHI on RBC aggregation and morphology using a rheometer and scanning electron microscopy (SEM), respectively. When mixed with sodium citrate, HM-CHI rapidly transformed human blood into an elastic gel. In contrast, un-modified chitosan (i.e. without hydrophobes) was unable to clot blood. The hydrophobias within HM-CHI entered into the RBC membranes and connected to the cells by a sample-spanning network, which subsequently led to the formation of an elastic gel. The gelling ability of HM-CHI is similar to that of fibrin-based sealants, but at a much lower cost and greater availability.

References

Jun 2, 1998·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·E I PeerschkeB Ghebrehiwet
Nov 26, 1999·Journal of Biomedical Materials Research·K OnoM Ishihara
Nov 24, 2001·Advanced Drug Delivery Reviews·H UenoT Fujinaga
Mar 11, 2003·Biomacromolecules·Marianne H NordbyJaan Roots
Sep 18, 2007·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Sabine KempeKarsten Mäder
Sep 22, 2007·Biotechnology Advances·In-Yong KimChong-Su Cho
Nov 13, 2007·International Journal of Pharmaceutics·Wanwisa KhunawattanakulThaned Pongjanyakul
Feb 19, 2008·The Journal of Surgical Research·Steven M AlstonS Fazal Mohammad
Feb 3, 2009·Colloids and Surfaces. B, Biointerfaces·Yuan WangMark L Denbow
May 19, 2009·International Journal of Biological Macromolecules·Ibrahim A Alsarra
Jan 1, 2008·Soft Matter·Laura A SmithPeter X Ma
Jan 26, 2011·Biotechnology Advances·R JayakumarH Tamura
Feb 8, 2011·Biomaterials·Matthew B DowlingSrinivasa R Raghavan
Apr 15, 2011·International Journal of Urology : Official Journal of the Japanese Urological Association·Keiichi IshiiToshikado Sugimoto
Jun 10, 2011·Surgical Laparoscopy, Endoscopy & Percutaneous Techniques·Rehan SaifSteve White
Sep 26, 2012·Physical Review. E, Statistical, Nonlinear, and Soft Matter Physics·J M BraderM Fuchs
Feb 26, 2013·Blood Reviews·Thierry BurnoufMirjana Radosevic
Aug 31, 2013·Carbohydrate Polymers·Z M dos SantosJ L C Fonseca
Oct 30, 2013·Bio-medical Materials and Engineering·Vinh Quang NguyenTakemi Matsui
Dec 24, 2013·International Journal of Biological Macromolecules·Bin ZhouBin Li
Feb 15, 2014·Knee Surgery, Sports Traumatology, Arthroscopy : Official Journal of the ESSKA·Zhi-Jun LiWei-Min Deng
Jul 14, 2014·The Journal of Surgical Research·Matthew B DowlingDavid R King
Aug 8, 2015·Macromolecular Rapid Communications·Zhanpeng Zhang, Peter X Ma
Oct 13, 2015·International Journal of Biological Macromolecules·Bon Kang GuChun-Ho Kim

❮ Previous
Next ❯

Citations

Aug 14, 2020·International Journal of Biological Macromolecules·Haroldo C B PaulaFlayanna G B Dias
Jul 18, 2020·Langmuir : the ACS Journal of Surfaces and Colloids·Ian C MacIntireSrinivasa R Raghavan

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.

Related Papers

Prevenzione stomatologica
P U Gennari, L Invernizzi
AJR. American Journal of Roentgenology
D C Smith, B S Bull
© 2022 Meta ULC. All rights reserved